Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Millennium Management LLC reported a 5.30% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 7, 2025
Millennium Management LLC reported a 5.30% stake in Lexeo Therapeutics, Inc., 2,836,292 shares, as a passive investor on Jun 30, 2025. Filed Aug 7, 2025 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 2,836,292
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 4.90% | 2,641,811 |
| Millennium Management LLC | 5.30% | 2,836,292 |
| Millennium Group Management LLC | 5.30% | 2,836,292 |
| Israel A. Englander | 5.30% | 2,836,292 |
Source
Related
- Lexeo Therapeutics, Inc.
- Millennium Management LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Nov 7, 2025
- Schedule 13G · Millennium Management LLC · Apr 28, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026